BLRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BioLine RX Ltd (BLRX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The stock shows bearish technical indicators, weak financial performance, and no significant positive catalysts or trading signals. It is better to hold off on investing in this stock until stronger signals or catalysts emerge.
The technical indicators for BLRX are bearish. The MACD is negative and expanding downward (-0.0043), the RSI is neutral at 38.237, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 2.885), with resistance at 3.153. There is no clear upward momentum.
NULL. There is no recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The company's financial performance in Q3 2025 is weak, with revenue dropping by -91.36% YoY and net income down -83.22% YoY. Additionally, the stock's implied volatility is extremely high (980.62), indicating significant uncertainty.
In Q3 2025, revenue dropped to $427,000 (-91.36% YoY), net income fell to -$977,000 (-83.22% YoY), and gross margin decreased to 80.33 (-3.65% YoY). EPS remained flat at 0. The financials indicate a significant decline in growth and profitability.
No data on analyst ratings or price target changes is available.
